Stress Management in Women with Hashimoto's thyroiditis: A Randomized Controlled Trial

Area of Science:

• Endocrinology and Immunology
• Psychoneuroimmunology
• Women's Health

Background:

• Stress is a potential factor in Hashimoto's thyroiditis pathogenesis.
• Limited research exists on stress management's efficacy in Hashimoto's thyroiditis patients.
• Hashimoto's thyroiditis affects thyroid hormone production and immune function.

Purpose of the Study:

• To assess the impact of an 8-week stress management intervention on key autoimmune markers in women with Hashimoto's thyroiditis.
• To evaluate changes in anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies, and thyroid-stimulating hormone (TSH) levels.
• To explore secondary effects on lifestyle, BMI, depression, anxiety, and stress levels.

Main Methods:

• A randomized controlled study with two arms: stress management intervention and standard care.
• Adult women diagnosed with Hashimoto's thyroiditis participated.
• Questionnaires and laboratory thyroid function tests were administered at baseline and after 8 weeks.

Main Results:

• The intervention group showed significant reductions in anti-TG antibody levels.
• Patients in the intervention group reported decreased stress, depression, and anxiety.
• Improvements in lifestyle scores were observed in the stress management group compared to the control group.

Conclusions:

• An 8-week stress management program can positively influence autoimmune markers and psychological well-being in women with Hashimoto's thyroiditis.
• Stress reduction strategies may be a valuable adjunct therapy for managing Hashimoto's thyroiditis.
• Further research is warranted to explore long-term effects and broader clinical implications.